---
layout: post
title: "3月29日板块复盘：中药板块7股涨停！又到了农业股表演的时候！京粮控股7天6板"
date: 2022-03-29 18:33:20 +0800
categories: dongfangcaifuyanjiuzhongxin
tags: 东方财富研究中心新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=0.000505&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 000505_0" data-code="K 000505|0|2" data-code2="K 000505|0|6|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></p><!-- EM_StockImg_End --><p>今日(3月29日) 沪深两市呈现震荡调整格局。A股三大指数早盘全线高开，盘初震荡整理之后，股指随后陷入跳水回落格局，午后延续反复震荡走弱，盘中偶有拉升表现，也迅速遭遇打压回落，尾盘股指再度跳水，最终三大指数全线微幅收跌。<br /></p><p>对此，国盛<span id="bk_90.BK0473"><a href="http://quote.eastmoney.com/unify/r/90.BK0473" class="keytip" data-code="90,BK0473">证券</a></span><span id="bkquote_90.BK0473"></span>指出，A股最差时刻正逐渐过去，今年指数低点大概率已经出现。考虑到当前市场仍然处于震荡磨底修复阶段，反转仍需等待，二次探底补缺后的A股随着更多稳增长政策出台和见效，资金或回流股市，悲观情绪也有望得到修复，指数重回升势可期，投资上建议保持成<span id="Info.116.00001"><a href="http://quote.eastmoney.com/unify/r/116.00001" class="keytip" data-code="116,00001">长和</a></span>价值的均衡配置。</p><p>与此同时，该机构进一步分析，在市场有效向上突破之前仍要控制好总体仓位适宜低吸，“稳增长”将成为驱动市场运行的主要逻辑，关注低估值、低配置的<span id="bk_90.BK0475"><a href="http://quote.eastmoney.com/unify/r/90.BK0475" class="keytip" data-code="90,BK0475">银行</a></span><span id="bkquote_90.BK0475"></span>和地产，建筑建材等传统基建，风电光伏等新型基建，建议结合<span id="Info.3321"><a href="http://data.eastmoney.com/bbsj/" class="infokey">业绩</a></span>性价比，适当布局化肥、疫情特效药等主题板块。</p><p><strong>板块方面：</strong></p><p><strong>一、<span id="bk_90.BK0433"><a href="http://quote.eastmoney.com/unify/r/90.BK0433" class="keytip" data-code="90,BK0433">农牧饲渔</a></span><span id="bkquote_90.BK0433"></span></strong></p><p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/90.BK0433" data-code="BK0433|90|1" data-code2="BK0433|90|2|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=90.BK0433&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 BK0433_0" data-code="K BK0433|90|1" data-code2="K BK0433|90|2|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>对于2022年农业行业机会，<span id="stock_1.601881"><a href="http://quote.eastmoney.com/unify/r/1.601881" class="keytip" data-code="1,601881">中国银河</a></span><span id="quote_1.601881"></span><span web="1" href="http://quote.eastmoney.com/unify/r/90.BK0473" class="em_stock_key_common" data-code="90,BK0473">证券</span>指出，坚定推荐猪周期。核心观点在于，在猪周期探底阶段，深度亏损期是布局养殖个股的最佳时机。从预期角度来说，不会再有更差的预期了，养殖个股风险被大量释放，安全边际很高。随着能繁母猪的数量下降和猪价再次下行，产能持续出清利好行业迎接曙光到来。周期行业股价先行，基于我们对22Q2-3二次探底的判断，预期22Q1是布局养殖个股的次优时点。<br /></p><p>另外，<span id="stock_0.002926"><a href="http://quote.eastmoney.com/unify/r/0.002926" class="keytip" data-code="0,002926">华西证券</a></span><span id="quote_0.002926"></span>提到，外围局势冲突催化下<span id="stock_0.000061"><a href="http://quote.eastmoney.com/unify/r/0.000061" class="keytip" data-code="0,000061">农产品</a></span><span id="quote_0.000061"></span>价格全面高涨，豆粕、小麦等<span web="1" href="http://quote.eastmoney.com/unify/r/0.000061" class="em_stock_key_common" data-code="0,000061">农产品</span>价格创下14年来新高，粮食安全问题显得愈发突出，进一步刺激种植产业链景气度提升。我国已通过的“新种子法”于2022年3月1日起实施，有利于加强种业知识产权保护和鼓励行业育种技术创新突破。甘肃省农业农村厅于近日发布了关于《甘肃省2022年农业转基因生物监管工作方案》的通知，通知中强调防止非法转基因农作物扩散，促进农业转基因的研究和应用健康发展。随着行业政策的不断完善和地方政府的严格监管，生物育种技术的应用将越来越近，如果“一号文件”相关制度出台顺利，对于前期获得转基因安全证书的种业企业而言重大意义。相关上市公司有<span id="stock_0.002385"><a href="http://quote.eastmoney.com/unify/r/0.002385" class="keytip" data-code="0,002385">大北农</a></span><span id="quote_0.002385"></span>、<span id="stock_0.000998"><a href="http://quote.eastmoney.com/unify/r/0.000998" class="keytip" data-code="0,000998">隆平高科</a></span><span id="quote_0.000998"></span>、<span id="stock_0.002041"><a href="http://quote.eastmoney.com/unify/r/0.002041" class="keytip" data-code="0,002041">登海种业</a></span><span id="quote_0.002041"></span>。</p><p><span id="stock_0.002736"><a href="http://quote.eastmoney.com/unify/r/0.002736" class="keytip" data-code="0,002736">国信证券</a></span><span id="quote_0.002736"></span>表示，看好2022年粮价景气上行。一方面利好种植及种子板块，另一方面饲料原材料成本的抬升或将加速猪价周期反转，看好生猪板块的投资机遇。具体标的方面，1)种植板块：推荐<span id="stock_1.601952"><a href="http://quote.eastmoney.com/unify/r/1.601952" class="keytip" data-code="1,601952">苏垦农发</a></span><span id="quote_1.601952"></span>、建议关注<span id="stock_1.600598"><a href="http://quote.eastmoney.com/unify/r/1.600598" class="keytip" data-code="1,600598">北大荒</a></span><span id="quote_1.600598"></span>。2)相关<span web="1" href="http://quote.eastmoney.com/unify/r/0.000061" class="em_stock_key_common" data-code="0,000061">农产品</span>板块：推荐<span id="stock_1.600737"><a href="http://quote.eastmoney.com/unify/r/1.600737" class="keytip" data-code="1,600737">中粮糖业</a></span><span id="quote_1.600737"></span>，建议关注<span id="stock_1.601118"><a href="http://quote.eastmoney.com/unify/r/1.601118" class="keytip" data-code="1,601118">海南橡胶</a></span><span id="quote_1.601118"></span>。3)种子板块：推荐<span web="1" href="http://quote.eastmoney.com/unify/r/0.000998" class="em_stock_key_common" data-code="0,000998">隆平高科</span>、<span web="1" href="http://quote.eastmoney.com/unify/r/0.002385" class="em_stock_key_common" data-code="0,002385">大北农</span>、<span web="1" href="http://quote.eastmoney.com/unify/r/0.002041" class="em_stock_key_common" data-code="0,002041">登海种业</span>等。4)生猪养殖板块推荐：<span id="stock_0.002840"><a href="http://quote.eastmoney.com/unify/r/0.002840" class="keytip" data-code="0,002840">华统股份</a></span><span id="quote_0.002840"></span>、<span id="stock_1.603363"><a href="http://quote.eastmoney.com/unify/r/1.603363" class="keytip" data-code="1,603363">傲农生物</a></span><span id="quote_1.603363"></span>、<span id="stock_1.603477"><a href="http://quote.eastmoney.com/unify/r/1.603477" class="keytip" data-code="1,603477">巨星农牧</a></span><span id="quote_1.603477"></span>、<span id="stock_0.002100"><a href="http://quote.eastmoney.com/unify/r/0.002100" class="keytip" data-code="0,002100">天康生物</a></span><span id="quote_0.002100"></span>、<span id="stock_0.001201"><a href="http://quote.eastmoney.com/unify/r/0.001201" class="keytip" data-code="0,001201">东瑞股份</a></span><span id="quote_0.001201"></span>、<span id="Info.116.01610"><a href="http://quote.eastmoney.com/unify/r/116.01610" class="keytip" data-code="116,01610">中粮家佳康</a></span>、<span id="stock_0.002714"><a href="http://quote.eastmoney.com/unify/r/0.002714" class="keytip" data-code="0,002714">牧原股份</a></span><span id="quote_0.002714"></span>、<span id="stock_0.300498"><a href="http://quote.eastmoney.com/unify/r/0.300498" class="keytip" data-code="0,300498">温氏股份</a></span><span id="quote_0.300498"></span>等。</p><center><img src="https://dfscdn.dfcfw.com/download/D25152103754805446191_w1080h1904.jpg" width="580" emheight="1023" orginial_src="https://dfscdn.dfcfw.com/download/D25152103754805446191_w1080h1904_o.jpg" style="border:#d1d1d1 1px solid;padding:3px;margin:5px 0;" /></center><p><strong>二、<span id="bk_90.BK1040"><a href="http://quote.eastmoney.com/unify/r/90.BK1040" class="keytip" data-code="90,BK1040">中药</a></span><span id="bkquote_90.BK1040"></span></strong></p><p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/90.BK1040" data-code="BK1040|90|1" data-code2="BK1040|90|2|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=90.BK1040&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 BK1040_0" data-code="K BK1040|90|1" data-code2="K BK1040|90|2|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>民生<span web="1" href="http://quote.eastmoney.com/unify/r/90.BK0473" class="em_stock_key_common" data-code="90,BK0473">证券</span>表示，中医药行业正处于逐步崛起阶段。1)中医药OTC 无集采风险，且院外市场拥有自主定价权，有助于产品保持较高的利润空间。我们重点关注两个方向，一是拥有独家品种、保密品种的标的，拥有高知识产权壁垒，建议关注<span id="stock_1.600085"><a href="http://quote.eastmoney.com/unify/r/1.600085" class="keytip" data-code="1,600085">同仁堂</a></span><span id="quote_1.600085"></span>、<span id="stock_1.600436"><a href="http://quote.eastmoney.com/unify/r/1.600436" class="keytip" data-code="1,600436">片仔癀</a></span><span id="quote_1.600436"></span>、<span id="stock_1.600976"><a href="http://quote.eastmoney.com/unify/r/1.600976" class="keytip" data-code="1,600976">健民集团</a></span><span id="quote_1.600976"></span>等；二是具有全渠道覆盖能力和品牌实力的标的，建议关注<span id="stock_0.000999"><a href="http://quote.eastmoney.com/unify/r/0.000999" class="keytip" data-code="0,000999">华润三九</a></span><span id="quote_0.000999"></span>、<span id="stock_1.600129"><a href="http://quote.eastmoney.com/unify/r/1.600129" class="keytip" data-code="1,600129">太极集团</a></span><span id="quote_1.600129"></span>、<span id="stock_1.600285"><a href="http://quote.eastmoney.com/unify/r/1.600285" class="keytip" data-code="1,600285">羚锐制药</a></span><span id="quote_1.600285"></span>等。2)中医诊疗服务方向获政策支持，处于快速增长期，建议关注民营中医连锁龙头<span id="Info.116.02273"><a href="http://quote.eastmoney.com/unify/r/116.02273" class="keytip" data-code="116,02273">固生堂</a></span>。3)在<span web="1" href="http://quote.eastmoney.com/unify/r/90.BK1040" class="em_stock_key_common" data-code="90,BK1040">中药</span>材溯源的趋势下，头部提供高质量<span web="1" href="http://quote.eastmoney.com/unify/r/90.BK1040" class="em_stock_key_common" data-code="90,BK1040">中药</span>饮片/配方颗粒的企业有望获益，建议关注<span id="Info.116.00570"><a href="http://quote.eastmoney.com/unify/r/116.00570" class="keytip" data-code="116,00570">中国中药</a></span>、<span id="stock_0.300026"><a href="http://quote.eastmoney.com/unify/r/0.300026" class="keytip" data-code="0,300026">红日药业</a></span><span id="quote_0.300026"></span>等。4)创新中药所处领域竞争格局良好，药物研发进入密集兑现期，建议关注<span id="stock_0.002603"><a href="http://quote.eastmoney.com/unify/r/0.002603" class="keytip" data-code="0,002603">以岭药业</a></span><span id="quote_0.002603"></span>、<span id="stock_0.002873"><a href="http://quote.eastmoney.com/unify/r/0.002873" class="keytip" data-code="0,002873">新天药业</a></span><span id="quote_0.002873"></span>、<span id="stock_1.603439"><a href="http://quote.eastmoney.com/unify/r/1.603439" class="keytip" data-code="1,603439">贵州三力</a></span><span id="quote_1.603439"></span>等。<br /></p><p>首创证券提到，中药板块龙头公司性价比明显，具有较高配置价值在新冠疫情之中，中医药发挥了重大作用，近年来随着高层对中医药事业的重视程度不断提升，各类支持中医药发展的政策陆续出台。特别是在2020-2021 年，中医药行业利好政策密集出台，涉及到药品审评、临床使用、医保支付、<span id="bk_90.BK0727"><a href="http://quote.eastmoney.com/unify/r/90.BK0727" class="keytip" data-code="90,BK0727">医疗服务</a></span><span id="bkquote_90.BK0727"></span>体系建设等诸多方面，中医药行业政策环境大幅度好转，行业有望迎来拐点。</p><p>该机构进一步建议，关注中药行业优质公司，具体思路如下：(1)品牌中药龙头，包括<span web="1" href="http://quote.eastmoney.com/unify/r/1.600085" class="em_stock_key_common" data-code="1,600085">同仁堂</span>、<span web="1" href="http://quote.eastmoney.com/unify/r/1.600436" class="em_stock_key_common" data-code="1,600436">片仔癀</span>；(2)中药创新药龙头公司，<span web="1" href="http://quote.eastmoney.com/unify/r/0.002603" class="em_stock_key_common" data-code="0,002603">以岭药业</span>、<span id="stock_1.600535"><a href="http://quote.eastmoney.com/unify/r/1.600535" class="keytip" data-code="1,600535">天士力</a></span><span id="quote_1.600535"></span>、<span web="1" href="http://quote.eastmoney.com/unify/r/0.002873" class="em_stock_key_common" data-code="0,002873">新天药业</span>和<span id="stock_1.600557"><a href="http://quote.eastmoney.com/unify/r/1.600557" class="keytip" data-code="1,600557">康缘药业</a></span><span id="quote_1.600557"></span>；(3)配方颗粒龙头<span web="1" href="http://quote.eastmoney.com/unify/r/116.00570" class="em_stock_key_common" data-code="116,00570">中国中药</span>和<span web="1" href="http://quote.eastmoney.com/unify/r/0.000999" class="em_stock_key_common" data-code="0,000999">华润三九</span>；(4)品牌价值明显的OTC 中成药企业，包括<span web="1" href="http://quote.eastmoney.com/unify/r/0.000999" class="em_stock_key_common" data-code="0,000999">华润三九</span>、<span web="1" href="http://quote.eastmoney.com/unify/r/1.600285" class="em_stock_key_common" data-code="1,600285">羚锐制药</span>和<span web="1" href="http://quote.eastmoney.com/unify/r/1.600976" class="em_stock_key_common" data-code="1,600976">健民集团</span>。从估值角度看，目前上述公司基本处于近5 年估值中枢附近，安全边际充足，具有较高的配置价值。</p><center><img src="https://dfscdn.dfcfw.com/download/D25266228773181894035_w1080h1889.jpg" width="580" emheight="1014" orginial_src="https://dfscdn.dfcfw.com/download/D25266228773181894035_w1080h1889_o.jpg" style="border:#d1d1d1 1px solid;padding:3px;margin:5px 0;" /></center><p><strong>一张图汇总：</strong></p><center><img src="https://dfscdn.dfcfw.com/download/D25146122085628530437_w523h546.jpg" width="523" emheight="546" orginial_src="https://dfscdn.dfcfw.com/download/D25146122085628530437_w523h546_o.jpg" style="border:#d1d1d1 1px solid;padding:3px;margin:5px 0;" /></center><p class="em_media">（文章来源：<span id="stock_0.300059"><a href="http://quote.eastmoney.com/unify/r/0.300059" class="keytip" data-code="0,300059">东方财富</a></span><span id="quote_0.300059"></span>研究中心）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202203292326826421>

[返回东方财富研究中心新闻](//finews.withounder.com/category/dongfangcaifuyanjiuzhongxin.html)｜[返回首页](//finews.withounder.com/)